Back to dashboard
CommercialPrior AuthMedium impact

Noxafil/Vfend

Blue Cross & Blue Shield of Mississippi·MS · Infectious Disease, Oncology, Hematology +1 more·Medical Policy
Effective date
Not stated
We identified it
Jun 20, 2026
Days to comply

Summary

BCBS Mississippi updated their medical policy for Noxafil (posaconazole) and Vfend (voriconazole) antifungal medications, requiring prior authorization for all uses. The policy establishes specific age requirements, diagnosis criteria, and approval lengths ranging from 1-6 months depending on the condition being treated.

Action Required

Action needed
Immediately: Billing team must update prior authorization requirements for Noxafil and Vfend prescriptions in billing system. Providers must obtain prior auth before prescribing these antifungal medications and ensure patients meet age requirements (2+ years for most indications, 13+ for posaconazole oral suspension). Document infectious disease specialist consultation as required. Claims will be denied without proper prior authorization.
Noxafil/Vfend | Blue Cross & Blue Shield of Mississippi | PolicyChanges.app